TRPM4 and diffuse large B-cell lymphoma: TRPM4 mRNA upregulation (together with the downregulation of other genes) in CD5+ subtypes of diffuse large B-cell lymphoma (DLBCL) patients was associated with a poorer prognosis compared with CD5− patients [189].